Cash Flow from Operating Activities (Annual)

Cash Flow from Operating Activities: A company's cash flows from operations.

Globus Medical, Inc. (GMED) had Cash Flow from Operating Activities of $243.50M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$1.57B
Net Income	$122.87M
Cost of Goods Sold	$548.17M
Gross Profit	$1.02B
Operating Expenses	$1.44B
Operating Income	$133.14M
Non-Operating Income/Expense	$32.25M
Pre-Tax Income	$165.39M
Normalized Pre-Tax Income	$165.39M
Income after Taxes	$122.87M
Income from Continuous Operations	$122.87M
Consolidated Net Income/Loss	$122.87M
Normalized Income after Taxes	$122.87M
EBIT	$133.14M
EBITDA	$358.50M
Weighted-Average Shares Outstanding (Basic)	113.09M
Weighted-Average Shares Outstanding (Diluted)	114.63M
Earnings per Share (EPS) (Basic)	$1.09
Earnings per Share (EPS) (Diluted)	$1.07
Balance Sheet Financials
Current Assets	$1.92B
Property, Plant, and Equipment	$586.93M
Long-Term Assets	$3.17B
Total Assets	$5.09B
Current Liabilities	$392.35M
Long-Term Debt	$417.40M
Long-Term Liabilities	$695.78M
Total Liabilities	$1.09B
Common Equity	$4.00B
Tangible Shareholders Equity	$1.64B
Shareholders Equity	$4.00B
Common Shares Outstanding	136.34M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$243.50M
Cash Flow from Investing Activities	$302.97M
Cash Flow from Financial Activities	$-231.82M
Beginning Cash	$150.47M
End Cash	$467.29M
Increase/Decrease in Cash	$316.83M
Stock-Based Compensation	$52.74M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.09
Debt to Equity Ratio	0.10
Gross Margin	65.05%
Operating Margin	8.49%
EBIT Margin	8.49%
EBITDA Margin	22.86%
Pre-Tax Profit Margin	10.54%
Profit Margin	7.83%
Free Cash Flow	$165.22M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.31
Inventory Turnover	0.65
Receiveable Turnover	3.11
Days Sales in Receivables	117.49
Return on Equity	3.07%
Return on Tangible Equity	7.50%
Return on Assets	2.42%
Return on Investments	2.78%
Book Value Per Share	$29.32
Free Cash Flow per Share	$1.44
Operating Cash Flow per Share	$2.12

Data from Zacks Investment Research, Inc.